Clinical Manifestation of -Thalassemia/Hemoglobin E Disease

Purpose: To review the clinical manifestation and changes in hematologic parameters of patients with -thalassemia/ hemoglobin (Hb) E. Materials and Methods: Retrospective analysis of the clinical manifestation of 378 patients with -thalassemia/Hb E attending the hematology clinic at Siriraj Hospital between 1957 and 1982. Results: A wide spectrum of clinical phenotypes has been observed. Most patients show clinical symptoms by 10 years of age. The majority of patients survive with or without occasional transfusion. Splenectomy was performed in 26.5% of patients. Patients come to the hospital because of anemia, fever, abdominal mass, and jaundice. Gastrointestinal tract disturbances are the most common presenting symptoms (34.6%), especially abdominal pain (10%) and cholecystitis (5.1%). Respiratory tract infections were found in 21.8% of patients and cardiovascular complications, including congestive heart failure, occurred in 11.9%. Other less common symptoms and complications included bone pain, chronic leg ulcers, paraplegia and hypertension-associated convulsions, and cerebral hemorrhage after multiple blood transfusion. Patients usually die between 20 to 40 years of age (67%), mainly from congestive heart failure and septicemia. Septicemia was often caused by Gramnegative bacteria. Conclusion: These clinical features observed in patients with -thalassemia/Hb E are probably the results of chronic anemia and iron overload. The study of the life history and clinical courses of patients with -thalassemia/Hb E should provide important information for the better management of these patients.

[1]  S. Chairoongruang,et al.  Gallstones in thalassemia. , 1988, Birth defects original article series.

[2]  P. Pootrakul,et al.  Serum ferritin levels in thalassemias and the effect of splenectomy. , 1981, Acta haematologica.

[3]  S. Na-nakorn,et al.  ALPHA‐ AND BETA‐THALASSEMIA IN THAILAND * , 1969, Annals of the New York Academy of Sciences.

[4]  S. Fucharoen,et al.  Intracranial extramedullary hematopoiesis inducing epilepsy in a patient with beta-thalassemia--hemoglobin E. , 1985, Archives of internal medicine.

[5]  S. Fucharoen,et al.  Determination for different severity of anemia in thalassemia: concordance and discordance among sib pairs. , 1984, American journal of medical genetics.

[6]  P. Wilairat,et al.  Severity differences in β‐thalassaemia/haemoglobin E syndromes: implication of genetic factors , 1993 .

[7]  S. Fucharoen,et al.  Hemoglobinopathies in Southeast Asia. , 1987, Hemoglobin.

[8]  S. Fucharoen,et al.  Severe infection in thalassemia: a prospective study. , 1987, Birth defects original article series.

[9]  P. Suwanagool,et al.  Distribution of pulmonary thromboembolic lesions in thalassemic patients. , 1987, Birth defects original article series.

[10]  S. Fucharoen,et al.  A study of infective episodes in patients with beta-thalassemia/Hb E disease in Thailand. , 1987, Birth defects original article series.

[11]  Thailand,et al.  Studies on hemoglobin E. I. The clinical, hematologic, and genetic characteristics of the hemoglobin E syndromes. , 1956, The Journal of laboratory and clinical medicine.

[12]  M. Naughton,et al.  Myoglobin: Inherited Structural Variation in Man , 1963, Science.

[13]  O. Smithies,et al.  Zone electrophoresis in starch gels: group variations in the serum proteins of normal human adults. , 1955, The Biochemical journal.

[14]  J. Burnell,et al.  Relation between erythropoiesis and bone metabolism in thalassemia. , 1981, The New England journal of medicine.

[15]  S. Issaragrisil,et al.  Spinal cord compression in thalassemia. Report of 12 cases and recommendations for treatment. , 1981, Archives of internal medicine.